Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novartis reports new apelin receptor agonists

Feb. 16, 2015

Vernalis and Servier patent novel Bcl-2 inhibitors

Feb. 16, 2015

Shanghai Institute Materia Medica discloses new alpha1A-adrenoreceptor antagonists

Feb. 16, 2015

The University of Colorado discloses new organosilicon anticancer agents

Feb. 13, 2015

Roche and Genentech patent describes new PAK 1 inhibitors

Feb. 13, 2015

Bayer Schering Pharma discloses GnRH receptor antagonists

Feb. 13, 2015

Novo Nordkisk reports development of anti-uPA MAbs

Feb. 13, 2015

Taisho Pharmaceutical divulges GlyT-1 inhibitors

Feb. 13, 2015

Novartis patent reports new complement factor B inhibitors

Feb. 12, 2015

MMV, Drexel University and University of Washington patent new antimalarials

Feb. 12, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...